Physician profile
Angelo J Colosimo
NPI 1881642734
$4,331.52
in general payments reported to CMS, 2019-2025
9 companies · $470 in 2025
The $470 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $894 · 2020: $506 · 2021: $355 · 2022: $316 · 2023: $645 · 2024: $1,145 · 2025: $470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,260.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,600.82 | 2019-2025 | Lens 4k, Healicoil, Bone Anchors With Arthroscopic Delivery System |
| Pacira Therapeutics, INC. | $402.79 | 2019-2021 | |
| Miach Orthopaedics, INC. | $120.65 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $55.30 | 2024-2025 | Exparel, Zilretta, Iovera |
| Stryker Corporation | $50.00 | 2019 | |
| Breg, INC | $49.70 | 2022 | |
| Ethicon US, LLC | $22.28 | 2020 | |
| Bioventus LLC | $17.19 | 2021 | |
| Paragon 28, INC. | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelo Colosimo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.